Managing Partners

Who We Are


Value Genome, LLC. is a team of pharmaceutical and biotech executives who share a common passion for assisting life science innovators to actualize the clinical and economic value of their assets. We combine our scientific, clinical, economic, and commercialization expertise with our extensive payer relations and industry experience.


  • We collaborate with you in developing market access strategies by looking at the clinical development program through product launch to reveal the CLINICAL and ECONOMIC VALUE of your asset as defined by key stakeholders.
  • We achieve this by engaging external stakeholders at all levels of health care delivery:
    • Government and Commercial Payers
    • Physician and Their Professional Societies
    • Healthcare and Insurance Networks
    • Patients and Patient Advocacy Organizations
    • Hospital and Treatment Centers
    • Health Technology Assessment Organizations

The goal is to shape your clinical development program to be payer ready and to optimize your product access globally.

Strategic Collaborators and Advisors

Stephen F Amato, Ph.D., MBA, RAC

Department Chair, Global Regulatory Affairs/Quality Assurance/ Advanced Manufacturering, Northeastern University


Joseph Eichenholz, MA

President, HealthCare Strategic Management, LLC


Mark Rubino, R.Ph, M.B.A.

Retired, Former Chief Pharmacy Officer Value Genome LLC